Tower Research Capital (TRC)’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.9K | Buy |
6,372
+2,104
| +49% | +$13.2K | ﹤0.01% | 3165 |
|
|
2025
Q1 | $25K | Buy |
4,268
+1,166
| +38% | +$6.83K | ﹤0.01% | 2767 |
|
|
2024
Q4 | $25.5K | Buy |
3,102
+403
| +15% | +$3.31K | ﹤0.01% | 3006 |
|
|
2024
Q3 | $24K | Sell |
2,699
-1,983
| -42% | -$17.7K | ﹤0.01% | 3137 |
|
|
2024
Q2 | $35.4K | Buy |
4,682
+1,528
| +48% | +$11.6K | ﹤0.01% | 3361 |
|
|
2024
Q1 | $24.8K | Sell |
3,154
-1,143
| -27% | -$8.97K | ﹤0.01% | 2806 |
|
|
2023
Q4 | $38.1K | Sell |
4,297
-2,307
| -35% | -$20.4K | ﹤0.01% | 3302 |
|
|
2023
Q3 | $59.2K | Buy |
6,604
+4,758
| +258% | +$42.7K | ﹤0.01% | 2404 |
|
|
2023
Q2 | $22.8K | Buy |
1,846
+770
| +72% | +$9.51K | ﹤0.01% | 3247 |
|
|
2023
Q1 | $10K | Sell |
1,076
-2,459
| -70% | -$22.9K | ﹤0.01% | 4326 |
|
|
2022
Q4 | $37K | Buy |
3,535
+2,273
| +180% | +$23.8K | ﹤0.01% | 2553 |
|
|
2022
Q3 | $23K | Sell |
1,262
-2,687
| -68% | -$49K | ﹤0.01% | 3804 |
|
|
2022
Q2 | $56K | Buy |
3,949
+2,840
| +256% | +$40.3K | ﹤0.01% | 2774 |
|
|
2022
Q1 | $24K | Buy |
1,109
+451
| +69% | +$9.76K | ﹤0.01% | 3353 |
|
|
2021
Q4 | $11K | Buy |
+658
| New | +$11K | ﹤0.01% | 4383 |
|